Neauvia wins "Best Injectable Dermal Filler" Award at AMWC 2024
Neauvia is honoured to announce its prestigious win at the AMWC 2024 Awards in Monaco. The company received the esteemed “Best Injectable Dermal Filler” award for its groundbreaking product, STIMULATE, the only PEG-HA + CaHA filler.
The AMWC 2024 Awards, internationally renowned for their commitment to acknowledging innovation and excellence in the global medical aesthetic market, spotlighted Neauvia as a leader in the category of Injectable Dermal Fillers. Winners were announced at AMWC Congress on March 27th, 2024.
STIMULATE stands out as the only PEG-HA + CaHA Filler in the market. It is a groundbreaking injectable made of Hyaluronic Acid (HA) cross-linked with PEG, enriched with Glycine, L-Proline and Calcium Hydroxyapatite (CaHA), offering effective solutions for skin and subcutaneous tissue concerns, including mid-face volume deficit correction. [Ref 1]
Neauvia remains dedicated to innovation in the Medical Aesthetics field, empowering healthcare practitioners worldwide.
Legal mentions and references:
Stimulate is class III medical device is regulated under the EU MDR 2017/745 Regulation. Manufacturer: MATEX LAB SPA, via Carlo Urbani 2 ang. via Enrico Fermi, Brindisi, Italy. Please carefully read the instructions in the leaflets. The use of these products requires the intervention of a healthcare professional. Only to be used by physicians in accordance with local legislation, trained in the injection techniques on Hyaluronic Acid based fillers.
1. Zerbinati N, D’Este E, De Silvestri A, Zullino M, Rabbiosi G, Guida S, Kubik P, Stabile G, Mocchi R, Barlusconi C et al. Efficacy of Pegylated Hyaluronic Acid filler enriched with Calcium Hydroxyapatite: a 24-week post-market, observational, prospective, open-label, single-center study. J. Funct. Biomater. 2023, 14, 345. https://doi.org/10.3390/jfb14070345.